The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Early safety from a phase I, multicenter, open-label clinical trial of talimogene laherparepvec (T-VEC) injected (inj) into liver tumors in combination with pembrolizumab (pem).
 
J. Randolph Hecht
Honoraria - ARMO BioSciences; AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Gritstone Bio; Halozyme; Ipsen; Merck; Roche
Research Funding - Abbvie (Inst); Advaxis (Inst); Amgen (Inst); ARMO BioSciences (Inst); Astellas Pharma (Inst); Forty Seven (Inst); Halozyme (Inst); Immunomedics (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Advaxis; Lilly
 
Miklos Pless
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Antonio Cubillo
No Relationships to Disclose
 
Aitana Calvo
Consulting or Advisory Role - Amgen; Lilly
Travel, Accommodations, Expenses - Amgen; Merck; SERVIER
 
Hong Jae Chon
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Eisai; Menarini; MSD; Ono Pharmaceutical; Sanofi; SERVIER; Sillajen
Speakers' Bureau - Celgene; Eisai; Ipsen; Menarini; Sanofi; SERVIER
Research Funding - Sillajen; Syntekabio
 
Chunxu Liu
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Amgen
Other Relationship - Amgen
 
Wendy Snyder
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Travel, Accommodations, Expenses - Amgen
 
Emily Chan
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Marya F. Chaney
Employment - Merck
Stock and Other Ownership Interests - Merck
Travel, Accommodations, Expenses - Merck
 
Jason Alan Chesney
Consulting or Advisory Role - Amgen; Replimune
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; MedImmune; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
Travel, Accommodations, Expenses - Amgen; Replimune
 
Aleix Prat
Employment - Novartis (I)
Honoraria - Amgen; Daiichi Sankyo; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Daiichi Sankyo; NanoString Technologies (Inst); Novartis; Oncolytics; Pfizer; Puma Biotechnology; Roche
Research Funding - Incyte (Inst); Novartis (Inst); Puma Biotechnology (Inst); Puma Biotechnology (Inst); Roche (Inst)
Patents, Royalties, Other Intellectual Property - PCT/EP2016/080056: HER2 AS A PREDICTOR OF RESPONSE TO DUAL HER2 BLOCKADE IN THE ABSENCE OF CYTOTOXIC THERAPY; WO/2018/096191. Chemoendocrine score (CES) Based on PAM50 for breast cancer with positive hormone receptors with an intermediate risk of recurrence
Travel, Accommodations, Expenses - Daiichi Sankyo
Other Relationship - Oncolytics; Peptomyc